# Structural and Functional Connectivity of Brainstem Monoamine Pathways in Treatment Resistant Depression

> **NCT03109717** · — · COMPLETED · sponsor: **Kathryn O'Connor** · enrollment: 11 (actual)

## Conditions studied

- Treatment Resistant Depression

## Interventions

- **DRUG:** Monoamine Oxidase Inhibitor (MAOI)

## Key facts

- **NCT ID:** NCT03109717
- **Lead sponsor:** Kathryn O'Connor
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2020-11
- **Final completion:** 2021-05
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2021-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03109717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03109717, "Structural and Functional Connectivity of Brainstem Monoamine Pathways in Treatment Resistant Depression". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03109717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*